Gembicen 200 mg, 1000mg, 2000mg Concentrate for solution for infusion
PDF Leaflet Revision Date: 22 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various cancers including non-small cell lung cancer and pancreatic cancer.
Dosage (summary)
1,000 mg/mu00b2 IV infusion over 30 mins, repeated weekly or as per specific cancer regimen.
Special Populations
- Elderly patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; breastfeeding should be discontinued.
Key Drug Interactions
- Cisplatin
- Paclitaxel
- Radiotherapy
Contraindications
- Hypersensitivity to gemcitabine
Common side effects
- Nausea
- Vomiting
- Leucopenia
- Dyspnoea
- Allergic skin rash
Counselling Points
- Monitor blood counts regularly
- Avoid live vaccines
- Caution with driving due to somnolence
Serious warnings
- Myelosuppression
- Posterior reversible encephalopathy syndrome
- Capillary leak syndrome
Important Disclaimer
The Gembicen 200 mg, 1000mg, 2000mg Concentrate for solution for infusion professional information leaflet below is the property of Pharma-Q Holdings and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
